A prospective, randomized, open label, phase III clinical trial of novoTTF-100A versus best standard of care chemotherapy in patients with recurrent glioblastoma Meeting Abstract


Authors: Stupp, R.; Kanner, A.; Engelhard, H.; Heidecke, V.; Taillibert, S.; Lieberman, F.; Dbaly, V.; Kirson, E. D.; Palti, Y.; Gutin, P. H.
Abstract Title: A prospective, randomized, open label, phase III clinical trial of novoTTF-100A versus best standard of care chemotherapy in patients with recurrent glioblastoma
Meeting Title: 9th Congress of The European Association of Neuro-Oncology (EANO)
Journal Title: Neuro-Oncology
Volume: 12
Issue: Suppl. 3
Meeting Dates: 2010 Sep 16-19
Meeting Location: Maastricht, The Netherlands
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2010-09-01
Start Page: ii3
Language: English
ACCESSION: ISI:000281184800011
PROVIDER: wos
DOI: 10.1093/neuonc/noq085
Notes: Meeting Abstract: O.10 -- "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Philip H Gutin
    163 Gutin